Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: Results from a population-based study on extranodal marginal zone lymphomas

Annals of Oncology

Volumn 21, Issue 4, 2009, Pages 855-859

  Luminari, S ^a   Cesaretti, M ^a   Marcheselli, L ^a   Rashid, I ^b   Madrigali, S ^a   Maiorana, A ^a   Federico, M ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b MODENA CANCER REGISTRY   (Italy)

Author keywords

Extranodal lymphoma; Gastric MALT; Helicobacter pylori; Incidence change; Non hodgkin's lymphoma; Population based study

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN LYMPHOMA; STOMACH LYMPHOMA; TREND STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; LYMPH NODES; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; POPULATION; REGISTRIES; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 77951955256     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp402     Document Type: Article

References (25)

1. Morton LM, Wang SS, Devesa SS et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-276.
2. Swerdlow SH, Campo E, Harris NL et al. The World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: WHO 2008.
3. Ferreri AJ, Zucca E. Marginal-zone lymphoma. Crit Rev Oncol Hematol 2007; 63: 245-256.
4. Zucca E, Conconi A, Pedrinis E et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101: 2489-2495.
5. Arcaini L, Burcheri S, Rossi A et al. Nongastricmarginal-zoneB-cellMALTlymphoma: prognostic value of disease dissemination. Oncologist 2006; 11: 285-291.
6. de Boer JP, Hiddink RF, Raderer M et al. Dissemination patterns in non-gastric MALT lymphoma. Haematologica 2008; 93: 201-206.
7. Luminari S, Cesaretti M, Rashid I et al. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Hematol Oncol 2007; 25: 189-197.
8. Fritz A, Percy C, Jack A et al. International Classification of Diseases for Oncology, 3rd edition. Geneva, Switzerland: World Health Organization 2000.
9. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36: 69-86.
10. Parkin DM, Plummer M. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 2002; 8: 57-73.
11. Silverman BW. Using kernel density estimates to investigate multimodality. J Roy Statist Soc Ser B 1995; 43: 97-99.
12. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. Technical report. Berlin, Germany: Springer-Verlag 1966.
13. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
14. Capelle LG, de Vries AC, Looman CW et al. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008; 44: 2470-2476.
15. Doglioni C, Wotherspoon AC, Moschini A et al. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992; 339: 834-835.
16. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
17. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000; 22: 283-297.
18. Mitchell HM. The epidemiology of Helicobacter pylori. Curr Top Microbiol Immunol 1999; 241: 11-30.
19. Lee SY, Park HS, Yu SK et al. Decreasing prevalence of Helicobacter pylori infection: a 9-year observational study. Hepatogastroenterology 2007; 54: 630-633.
20. Tkachenko MA, Zhannat NZ, Erman LV et al. Dramatic changes in the prevalence of Helicobacter pylori infection during childhood: a 10-year follow-up study in Russia. J Pediatr Gastroenterol Nutr 2007; 45: 428-432.
21. Apostolopoulos P, Vafiadis-Zouboulis I, Tzivras M et al. Helicobacter pylori (H pylori) infection in Greece: the changing prevalence during a ten-year period and its antigenic profile. BMC Gastroenterol 2002; 2: 11.
22. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34: 1672-1676.
23. Take S, Mizuno M, Ishiki K et al. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005; 100: 1037-1042.
24. Fukase K, Kato M, Kikuchi S et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397.
25. Rashid I, Artioli ME, Braghiroli B et al. I tumori in provincia di Modena; anni 1988-2006. Edition Modena: Associazione Angela Serra per la Ricerca sul Cancro 2008.